Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice
about
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitisHuman central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
P2860
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Blockade of B-cell activating ...... llergic encephalomyelitis mice
@ast
Blockade of B-cell activating ...... llergic encephalomyelitis mice
@en
type
label
Blockade of B-cell activating ...... llergic encephalomyelitis mice
@ast
Blockade of B-cell activating ...... llergic encephalomyelitis mice
@en
prefLabel
Blockade of B-cell activating ...... llergic encephalomyelitis mice
@ast
Blockade of B-cell activating ...... llergic encephalomyelitis mice
@en
P2093
P2860
P356
P1476
Blockade of B-cell activating ...... llergic encephalomyelitis mice
@en
P2093
Beifen Shen
Chunmei Hou
Gencheng Han
Guojiang Chen
Renxi Wang
Xiaoling Liu
Xiaoqian Wang
P2860
P304
P356
10.5114/CEJI.2015.52826
P50
P577
2015-08-03T00:00:00Z